SGN-30

brentuximab vedotin · Seagen

Drug timelines are a Plus or Pro feature.

3 regulatory and trial events tracked for SGN-30, covering 2011-10-12 to 2014-12-18. Get the full timeline:

Most recent: Clinical Trial Update: Study of SGN-30 (Antibody) in Patients With Refractory or Recurrent Anaplastic Large Cell Lymphoma [Phase 2]